ReP USP - Resultado da busca

Filtros : "ICB" "ZORN, TELMA MARIA TENORIO" "HEPATOPATIAS" Limpar

Filtros

USP affiliated authors
- morais, mychel raony paiva teixeira (2)
- zorn, telma maria tenorio (2)
- castro, érique de (1)
- chaves filho, adriano de britto (1)
- cogliati, bruno (1)

Artigo de periodico
Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice (2020)
Silva, Aline David; Esteves, João Victor Del Conti ; Morais, Mychel Raony Paiva Teixeira ; Freitas, Helayne Soares ; Zorn, Telma Maria Tenório; Giannella, Maria Lucia Cardillo Correa ; Machado, Ubiratan Fabres
Source: Diabetes, Metabolic Syndrome and Obesity. Unidades: ICB, FM
Subjects: FISIOLOGIA, BIOLOGIA CELULAR, DIABETES MELLITUS, GLICOSE, GLICEMIA, HOMEOSTASE, CAMUNDONGOS, INFLAMAÇÃO, HEPATOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Aline David et al. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice. Diabetes, Metabolic Syndrome and Obesity, v. 2020, p. 739—751, 2020Tradução . . Disponível em: https://doi.org/10.2147/DMSO.S242282. Acesso em: 09 nov. 2024.
APA
Silva, A. D., Esteves, J. V. D. C., Morais, M. R. P. T., Freitas, H. S., Zorn, T. M. T., Giannella, M. L. C. C., & Machado, U. F. (2020). Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice. Diabetes, Metabolic Syndrome and Obesity, 2020, 739—751. doi:10.2147/DMSO.S242282
NLM
Silva AD, Esteves JVDC, Morais MRPT, Freitas HS, Zorn TMT, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice [Internet]. Diabetes, Metabolic Syndrome and Obesity. 2020 ; 2020 739—751.[citado 2024 nov. 09 ] Available from: https://doi.org/10.2147/DMSO.S242282
Vancouver
Silva AD, Esteves JVDC, Morais MRPT, Freitas HS, Zorn TMT, Giannella MLCC, Machado UF. Dual SGLT1/SGLT2 inhibitor phlorizin ameliorates non-alcoholic fatty liver disease and hepatic glucose production in type 2 diabetic mice [Internet]. Diabetes, Metabolic Syndrome and Obesity. 2020 ; 2020 739—751.[citado 2024 nov. 09 ] Available from: https://doi.org/10.2147/DMSO.S242282
Artigo de periodico
Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids (2020)
Moreira, Rafael Junges; Castro, Érique de ; Silva, Tiago Eugênio Oliveira da; Oliveira, Thiago Belchior de; Peixoto, Albert Souza ; Chaves Filho, Adriano de Britto; Moreno, Mayara Franzoi ; Lima, Janayna Dias; Yoshinaga, Marcos Yukio ; Miyamoto, Sayuri ; Morais, Mychel Raony Paiva Teixeira; Zorn, Telma Maria Tenório; Cogliati, Bruno ; Iwai, Leo Kei; Palmisano, Giuseppe ; Cabral, Fernanda Janku; Festuccia, William Tadeu Lara
Source: Molecular Nutrition & Food Research. Unidades: IQ, ICB, FMVZ
Subjects: FISIOLOGIA, BIOLOGIA CELULAR, PARASITOLOGIA, RESISTÊNCIA À INSULINA, ÁCIDOS GRAXOS, INGESTÃO, HOMEOSTASE, GLICOSE, HEPATOPATIAS, FÍGADO GORDUROSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Rafael Junges et al. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids. Molecular Nutrition & Food Research, p. 13 , 2020Tradução . . Disponível em: https://doi.org/10.1002/mnfr.201900833. Acesso em: 09 nov. 2024.
APA
Moreira, R. J., Castro, É. de, Silva, T. E. O. da, Oliveira, T. B. de, Peixoto, A. S., Chaves Filho, A. de B., et al. (2020). Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids. Molecular Nutrition & Food Research, 13 . doi:10.1002/mnfr.201900833
NLM
Moreira RJ, Castro É de, Silva TEO da, Oliveira TB de, Peixoto AS, Chaves Filho A de B, Moreno MF, Lima JD, Yoshinaga MY, Miyamoto S, Morais MRPT, Zorn TMT, Cogliati B, Iwai LK, Palmisano G, Cabral FJ, Festuccia WTL. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids [Internet]. Molecular Nutrition & Food Research. 2020 ; 13 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/mnfr.201900833
Vancouver
Moreira RJ, Castro É de, Silva TEO da, Oliveira TB de, Peixoto AS, Chaves Filho A de B, Moreno MF, Lima JD, Yoshinaga MY, Miyamoto S, Morais MRPT, Zorn TMT, Cogliati B, Iwai LK, Palmisano G, Cabral FJ, Festuccia WTL. Lipoatrophy-associated insulin resistance and hepatic steatosis are attenuated by intake of diet rich in omega 3 fatty acids [Internet]. Molecular Nutrition & Food Research. 2020 ; 13 .[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/mnfr.201900833

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024